Accelerated Infliximab Infusion: Safety, Factors Predicting Adverse Events, Patients’ Satisfaction and Cost Analysis. A Cohort Study in IBD Patients

BACKGROUND: Standard Infliximab infusion consists of a 2-hour intravenous administration. Recently, Infliximab shortened infusion has been included in the Infliximab label as possible maintenance regimen for patients tolerating Infliximab induction therapy. AIM: To verify if accelerated 1-hour Infli...

Descripción completa

Detalles Bibliográficos
Autores principales: Mazzuoli, S., Tricarico, D., Demma, F., Furneri, G., Guglielmi, F. W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5112916/
https://www.ncbi.nlm.nih.gov/pubmed/27851772
http://dx.doi.org/10.1371/journal.pone.0166443

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5112916/
https://www.ncbi.nlm.nih.gov/pubmed/27851772
http://dx.doi.org/10.1371/journal.pone.0166443

Ejemplares similares